

Foreword
Since their discovery, CRISPR-based systems have fundamentally transformed our ability to manipulate
genomes. When combined with stem cells, these gene-editing tools also have the power to reshape
our understanding of human genetics, developmental biology, and regenerative medicine. The reviews
and research in this edition of
Cell Press Selections
, on gene editing in stem cells, offer a snapshot of
the latest advances in this rapidly evolving field.
As CRISPR/Cas9 systems, next-generation genome sequencing, and stem cell technologies have
matured, so too have the possibilities for their combined use. CRISPR-based platforms have already
been successfully applied in stem cells to address basic questions about human biology and produce
experimental tools for disease modeling and drug discovery. Looking forward, it seems inevitable that
applications of CRISPR technologies will continue to expand their reach, with the first CRISPR-based
stem cell therapies already entering clinical testing. The articles compiled in this reprint collection
showcase the current progress in these areas, from new CRISPR-based stem cell platforms for
disease modeling and therapeutic development to alternative approaches for using CRISPR as a cell
biology tool.
These articles represent only a small portion of the exciting research Cell Press has published and will
publish on gene editing in stem cells, and we hope you’ll visit
www.cell.comon a regular basis to keep
up with the latest stem cell and genome-editing news.
Finally, we are grateful for the support of OriGene, who helped to make the publication of this collection
possible.
Sheila Chari
Senior Scientific Editor,
Cell Stem Cell
For more information about
Cell Press Selections:
Jonathan Christison
Program Director
jchristison@cell.com617-397-2893